|
544319 SENORES Group (A) 02 Sep,15:28
1450.90
-2.65 (-0.18%)
HOW HOT IS THIS STOCK?
Last 15 days data © Rediff.com Add to Watchlist
|
BSE | NSE
 ZoomRefreshDay
Wk
Mn
6Mn
Yr
|
Invest & Trade in SENORES on dhan
1 min read
5 hours ago
1 min read
6 hours ago
1 min read
6 hours ago
1 min read
7 hours ago
| Mar ' 26 | Mar ' 25 | Mar ' 24 | Mar ' 22 | Mar ' 21 | |
|---|---|---|---|---|---|
| Sales | 106.09 | 38.54 | 34.01 | 15.85 | 7.91 |
| Operating profit | -18.68 | -7.28 | -0.06 | 0.93 | 1.01 |
| Interest | 6.98 | 6.52 | 2.71 | 0.49 | 0.20 |
| Gross profit | 40.69 | 8.19 | 4.07 | 1.48 | 0.97 |
| EPS (Rs) | 4.40 | 0.80 | 0.27 | 0.34 | 2.20 |
1 min read
5 hours ago
1 min read
5 hours ago
Q: What is the current share price of Senores Pharmaceuticals Ltd.?
A: The current share price of Senores Pharmaceuticals Ltd. is ₹ 1450.90 (for BSE as on 02 Sep,15:28). The 52-week range is ₹ 1,599.55 - 661.65. Prices are updated based on live market data.
Q: What is the market capitalization of Senores Pharmaceuticals Ltd.?
A: Senores Pharmaceuticals Ltd. has a market capitalization of ₹ 6,688.65 Cr, making it a company.
Q: What is the PE ratio of Senores Pharmaceuticals Ltd.?
A: The Price-to-Earnings (PE) ratio of Senores Pharmaceuticals Ltd. is 329.95, indicating its valuation relative to earnings.
Q: Is Senores Pharmaceuticals Ltd. a good investment?
A: Senores Pharmaceuticals Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.
Q: What are the latest financial results of Senores Pharmaceuticals Ltd.?
A: Senores Pharmaceuticals Ltd. has reported its latest annual results with revenue of ₹ 106.09 and net profit/loss of ₹ 20.25.
